Aura Biosciences, Inc. (AURA) — Capital Expenditures
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $447.0K | -64.3% |
| 2024 | $1.25M | +76.7% |
| 2023 | $709.0K | -35.2% |
| 2022 | $1.09M | -48.5% |
| 2021 | $2.12M | +175.6% |
| 2020 | $771.0K | — |
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $447.0K | -64.3% |
| 2024 | $1.25M | +76.7% |
| 2023 | $709.0K | -35.2% |
| 2022 | $1.09M | -48.5% |
| 2021 | $2.12M | +175.6% |
| 2020 | $771.0K | — |